In GH secreting adenomas, octreotide and lanreotide, mainly acting on sst2 and slightly less effectively on sst5, inhibit GH secretion [153], normalize IGF-1 serum levels, and cause tumor size reduction [154]. This evidence concerns the gene SSTR5 and neoplasm.